about
MicroRNA and signal transduction pathways in tumor radiation responsePARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directionsGenome stability pathways in head and neck cancersMolecular Insights into Poly(ADP-ribose) Recognition and Processing.E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factorAcetylation of Werner syndrome protein (WRN): relationships with DNA damage, DNA replication and DNA metabolic activities.Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone.Role of AKT signaling in DNA repair and clinical response to cancer therapy.Basal activity of a PARP1-NuA4 complex varies dramatically across cancer cell lines.Rapamycin-resistant poly (ADP-ribose) polymerase-1 overexpression is a potential therapeutic target in lymphangioleiomyomatosis.Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.Human RecQ helicases in DNA repair, recombination, and replication.Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2.PARP-1 inhibition influences the oxidative stress response of the human lens.TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapyDNA damage tolerance: a double-edged sword guarding the genomeThe La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.CTCF participates in DNA damage response via poly(ADP-ribosyl)ation.The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells.Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathwayThe interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability.NELF-E is recruited to DNA double-strand break sites to promote transcriptional repression and repair.Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin.Alkylation induced cerebellar degeneration dependent on Aag and Parp1 does not occur via previously established cell death mechanisms.Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials.The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.DNA damage-induced histone H1 ubiquitylation is mediated by HUWE1 and stimulates the RNF8-RNF168 pathway.CDYL1 fosters double-strand break-induced transcription silencing and promotes homology-directed repair.PARPi potentiates with current conventional therapy in MLL leukemia.Metabolic Reprogramming During Multidrug Resistance in Leukemias.A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf-Hirschhorn syndrome.Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair.
P2860
Q27027546-5D7117B0-3AE7-431B-B737-B882C08620E5Q28071345-1A1BDC82-88B4-412B-B206-86323DE9B1C6Q28391355-30F37884-0F5F-42B4-9C6F-C2E67CBB3A63Q33649646-25F9C493-CB95-491E-9435-3B078C9C3704Q33708518-B89C7161-8F74-4FD7-9504-626CC700178AQ34004402-E9AA8529-2106-403F-930B-7BECECDBD277Q34144527-E321F158-E461-4B5C-AACF-0B8972440028Q34193741-1FDC0EDC-7501-49C1-86F2-AC91B991371AQ34254927-E2D49F97-38CE-4355-9946-9AF8773C5E49Q34924914-529CE0BA-05A3-48E7-9457-6DCA21DA03B9Q35895214-13659E83-203A-4DA1-9D11-C81E559F5E0CQ35978719-002E2ACC-CAB2-4EB9-9F67-6542517D0889Q36101160-86C33A35-34DC-4C28-933E-8F6B2C3085A2Q36234283-9D733E10-B7B6-46C8-A68F-60B329831BD0Q36703885-6CCC8FD8-5E5B-4A17-B456-72B9E98986ABQ37185105-618B16F0-9AE3-48C9-87AD-DCA98AF5BB19Q37187991-70F6735D-C554-4B0B-83A0-B8AC65F548EFQ37438751-464E7960-A571-4378-9FD8-EB05F2D5598DQ37681804-C28C7A9D-458B-43F8-BDF2-3AEBC12E67D1Q38142158-E40DB7C7-3B0B-41A4-8550-C78326F39F66Q38200674-4A84A1F5-D264-4F87-81E9-2A51C06E56B4Q38292041-76D403BD-F643-49E4-A9CA-F5B46D29C786Q38450793-0B312A99-A31D-4294-84BB-E984DAE347B7Q38880991-D266E1E9-D1DB-4982-83FD-19237C73110EQ39142926-4FE23E81-1B39-4151-8070-B34049D96CDCQ39204989-0177BE15-18D8-4B9B-8BCF-3F12278ABAB6Q41489232-A7A3CD04-EB33-47C4-8858-EDF73F674F4CQ42673155-D683CFA3-C93D-4B97-AA65-58D915AB9BDDQ42826404-4D48314D-83EF-4D72-A52D-B48EF974E5FEQ47209621-12E05567-8C12-4841-9CFE-6B05B95AAAC7Q47362873-C87E1FD5-F0DE-416D-BB20-5298A8DE21BFQ47833710-04ECC28E-7B1C-485A-BC81-B9F229D83D7BQ52575780-9ADC2BDE-3031-4843-A6DA-1088162453F6Q54586051-E44B3522-2A93-4F4A-9D9B-4CDDCF005DA3Q55100687-A57B945B-38A2-4D80-9FF1-17A58691469FQ55314044-9E427169-5203-46B2-B299-68683A727161
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
PARPs and the DNA damage response
@ast
PARPs and the DNA damage response
@en
PARPs and the DNA damage response
@nl
type
label
PARPs and the DNA damage response
@ast
PARPs and the DNA damage response
@en
PARPs and the DNA damage response
@nl
prefLabel
PARPs and the DNA damage response
@ast
PARPs and the DNA damage response
@en
PARPs and the DNA damage response
@nl
P2093
P2860
P3181
P356
P1433
P1476
PARPs and the DNA damage response
@en
P2093
Annette K Larsen
Daniele G Soares
Jenifer Saffi
João A P Henriques
Renata Matuo
P2860
P304
P3181
P356
10.1093/CARCIN/BGS132
P407
P577
2012-03-19T00:00:00Z